Chapter 4 - FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8)
-
Add time:08/27/2019 Source:sciencedirect.com
Publisher SummaryThis chapter describes fexofenadine hydrochloride (FEX), its nomenclature, formulae, methods of preparation, physical properties, and methods of analysis, stability, drug metabolism, and pharmacokinetics. FEX is obtained as a white to off-white crystalline powder. FEX is a nonsedating, second-generation H1 antihistamine, which acts as a reversible and competitive inhibitor at H1 histamine receptor sites. The drug is an active carboxylic acid metabolite of terfenadine, and provides all the therapeutic benefits of terfenadine, while avoiding the serious cardiotoxic and drug interaction risks of the parent drug, and is therefore, considered as a relatively safe alternative to terfenadine. The synthetic approach for preparation of FEX involves the reduction of a carboxylate derivative, 4-[4-[4-(hydroxybiphenylmethyl)-1-piperidinyl]-1-oxobutyl]-a,a-dimethyl benzene acetate; followed by hydrolysis with a base, for example alkali metal hydroxides, to get the carboxylic acid derivative FEX. FEX exists as a zwitterion in aqueous media at physiological pH. The drug has two ionization groups corresponding to free carboxylic group on the side chain and the substituted ring nitrogen, contributing to a pKa value of 4.25 and 9.53, respectively. FEX is stable under normal storage conditions, but the substance is stored in tight containers and protected from light and humidity. Photodegradation of FEX is studied using a stability indicating high performance liquid chromatography (HPLC) assay method.
We also recommend Trading Suppliers and Manufacturers of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8). Pls Click Website Link as below: cas 138452-21-8 suppliers
Prev:ORIGINAL ARTICLESpectrofluorimetric determination of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) in pharmaceutical preparation using silver nanoparticles
Next:Effect of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) on cedar pollinosis) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Isolation and structure elucidation of photodegradation products of fexofenadine09/01/2019
- Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8)08/31/2019
- Original Articles: InterventionsSafety and tolerability of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8), 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis08/30/2019
- Pharmaceutics, Preformulation and Drug DeliveryPoloxamer/Cyclodextrin/Chitosan-Based Thermoreversible Gel for Intranasal Delivery of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8)08/29/2019
- Effect of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) on cedar pollinosis08/28/2019
- ORIGINAL ARTICLESpectrofluorimetric determination of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) in pharmaceutical preparation using silver nanoparticles08/26/2019
- Original ArticleDevelopment and validation of RP-HPLC method for simultaneous estimation of Montelukast Sodium and FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) in combined dosage form08/25/2019
- Formulation and evaluation of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) orally disintegrating tablets for pediatric use08/24/2019
- CommunicationHigh-throughput measurements of ciprofloxacin, clomipramine and FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8)s with an 8-channel electrical titrator08/23/2019
-
Health and Chemical more >


